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Physiopathological function of hematoside (GM3 ganglioside)
By Jin-ichi INOKUCHI*1,†
(Communicated by Kunihiko SUZUKI, M.J.A.)
Abstract: Since I was involved in the molecular cloning of GM3 synthase (SAT-I), which is
the primary enzyme for the biosynthesis of gangliosides in 1998, my research group has been
concentrating on our eﬀorts to explore the physiological and pathological implications of
gangliosides especially for GM3. During the course of study, we demonstrated the molecular
pathogenesis of type 2 diabetes and insulin resistance focusing on the interaction between insulin
receptor and gangliosides in membrane microdomains and propose a new concept: Life style-related
diseases, such as type 2 diabetes, are a membrane microdomain disorder caused by aberrant
expression of gangliosides. We also encountered an another interesting aspect indicating the
indispensable role of gangliosides in auditory system. After careful behavioral examinations of
SAT-I knockout mice, their hearing ability was seriously impaired with selective degeneration of the
stereocilia of hair cells in the organ of Corti. This is the ﬁrst observation demonstrating a direct link
between gangliosides and hearing functions.
Keywords: GM3 ganglioside, GM3 synthase (SAT-I), insulin resistance, membrane
microdomains (lipid rafts), auditory system, hearing loss
Introduction
In 1951, the presence of sialic acid at the surface
of cell membranes was ﬁrst demonstrated by Tamio
Yamakawa.1) He isolated a sialic acid-containing
substance from 100g of dried ghosts obtained from 10
liters of packed horse erythrocytes and named the
glycolipid hematoside.1),2) Hematoside is now also
called GM3 ganglioside because this substance is the
ﬁrst product in the biosynthetic pathway of the
ganglio-series gangliosides. GM3 serves as a common
precursor for complex gangliosides such as the a- and
b-series gangliosides (Fig. 1). “Gangliosides expressed
in a cell-type speciﬁc manner” in the outer leaﬂet of
the cell membranes are expected to interact with
various molecules on plasma membranes based on
diﬀerent potentials of non-covalent bonding such as
electrostatic and hydrophobic interactions and there-
by ganglioside family could participate in various
aspects of cellular activities by forming dynamic
functional complexes (membrane microdomains
or lipid rafts).3),4) Expression levels of cellular
gangliosides are known to be inﬂuenced by various
extracellular stimuli including inﬂammatory cyto-
kines. Namely, the presence of gangliosides in
membrane microdomains is reﬂecting the character-
istics of individual cells under various physiological
and pathological environments. Since I was involved
in gene cloning of “GM3 synthase” in 1988,5) much
eﬀorts of our research group have been dedicated to
the elucidation of biological function of GM3. GM3
synthase (CMP-N-acetylneuraminate:lactosylceramide-
,-2,3-N-acetylneuraminyltransferase; EC 2.4.99.9),
also known by the names SAT-I (used here),
ST3GalV, and Siat 9. This review describes our
ﬁndings on the physiopathological signiﬁcance of
gangliosides especially for GM3 in diabetes and
hearing loss.
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A new concept, that ‘‘metabolic disorders, such
as type 2 diabetes, are membrane microdomain
disorders caused by aberrant expression of ganglio-
sides”, has arisen. By examining this working
hypothesis, we demonstrate the molecular patho-
genesis of type 2 diabetes and insulin resistance
focusing on the interaction between insulin receptor
and gangliosides in microdomains and propose the
new therapeutic strategy ‘‘membrane microdomain
ortho-signaling therapy”.
1-1. GM3 is an inducer of insulin resistance.
Insulin elicits a wide variety of biological activities,
which can be categorized into metabolic and mitogenic
actions. The binding of insulin to insulin receptor
(IR) activates IR internal-tyrosine kinase activity.
The activated tyrosine-phosphorylated IR was able to
recruit and phosphorylate adaptor proteins such as
insulin receptor substrate (IRS). The phosphorylated
IRS activates PI3-kinase, resulting in the transloca-
tion of glucose transporter 4 (GLUT-4) to plasma
membrane to facilitate glucose uptake. This IR–IRS–
PI3-kinase signaling cascade is the representative
metabolic pathway triggered by insulin. On the other
hand, the mitogenic pathway in insulin signaling
initiates phosphorylation of Shc by the activated IR
and then activates Ras-MAPK signaling.
When mouse adipocytes were cultured in low
concentrations of TNF, which do not cause gener-
alized suppression of adipocyte gene expression
including IRS-1 and GLUT-4, interference of insulin
action by TNF, occurred.6) This requires prolonged
treatment (at least 72h), unlike many acute eﬀects
of this cytokine. The slowness of the eﬀect suggests
that TNF, insulin resistance in adipocytes treated
with 0.1nM TNF, was accompanied by a progressive
increase in cell surface GM3. This was reﬂected by
increases in cellular GM3 content, GM3 synthase
activity and GM3 synthase mRNA content, indicat-
ing that TNF, upregulates GM3 synthesis at the
transcriptional level in cultured adipocytes.7) To
elucidate whether the increased GM3 in 3T3-L1
adipocytes treated with TNF, is involved in insulin
resistance, we used an inhibitor of glucosylceramide
synthase, D-threo-1-phenyl-2-decanoylamino-3-mor-
pholino-1-propanol (D-PDMP)8) to deplete cellular
glycosphingolipids derived from glucosylceramide.
D-PDMP proved able to counteract TNF-induced
increase of GM3 content in adipocytes and com-
pletely normalize the TNF-induced defect in tyrosine
phosphorylation of IRS-1 in response to insulin
stimulation (Fig. 2A). These ﬁndings are supported
by the observation that knockout mouse lacking
GM3 synthase exhibits enhancement of insulin
signaling.9)
Hotamisligil et al. reported that treatment of
adipocytes with TNF, induces an increase in the
serine phosphorylation of IRS-1.10) This phospho-
rylation is an important event since immunoprecipi-
Fig. 1. Biosynthesis of ganglio-series gangliosides.
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in response to TNF,, is a direct inhibitor of insulin
receptor tyrosine kinase activity. We have shown that
TNF, induced serine phosphorylation of IRS-1 in
adipocytes was completely suppressed by inhibition of
GM3 biosynthesis with D-PDMP treatment, suggest-
ing that the elevated GM3 synthesis induced by
TNF, caused the upregulation of serine phospho-
rylation of IRS-1 (Fig. 2B).7) Since TNF-induced
serine phosphorylation of IRS-1 may occur through
the activation of a variety of kinases including protein
kinase C, c-Jun NH2-terminal kinase, p44/42 kinase,
and PI3-kinase, it is important to identify the actual
kinase(s) activated by endogenous GM3. Zucker fa/fa
rat produced signiﬁcant levels of TNF,.10) Much less
expression was seen in adipose tissues obtained from
the lean control animals. Interestingly, these obese-
diabetic animals did not show evidence of altered ex-
pression of other cytokines, such as IL-1 or IFN..10),11)
Thus, we were interested in measuring the expression
of GM3 synthase mRNA in the epididymal fat of
Zucker fa/fa rats and ob/ob mice. Northern blot
analysis of GM3 synthase mRNA contents in the
adipose tissues from these two typical models of
insulin resistance exhibited signiﬁcantly high levels
compared to their lean counterparts (Fig. 3).7)
1-2. Caveolae microdomains and insulin
signaling. Caveolae are a subset of membrane
microdomains particularly abundant in adipo-
cytes.12),13) Critical dependence of the insulin meta-
bolic signal transduction on caveolae/microdomains
in adipocytes has been demonstrated.14),15) Disrup-
tion of microdomains by cholesterol extraction with
methyl-O-cyclodextrin resulted in progressive inhib-
ition of tyrosine phosphorylation of IRS-1 and
activation of glucose transport in response to insulin
although autophosphorylation of IR and activation
of MAP kinase were not impaired.12) Similarities
between these cell culture results and the ﬁndings
in many cases of clinical insulin resistance suggest a
potential role for microdomains in the pathogenesis
of this disorder.16) Couet et al. demonstrated the
presence of a caveolin binding motif (fXXXXfXXf)
[f: an aromatic amino acid, X: any amino acid] in
the O subunit of IRs that could bind to the scaﬀold
domain of caveolin.17) Moreover, mutation of this
motif resulted in the inhibition of insulin signaling.18)
Indeed, mutations of the IRO-subunit have been
found in type 2 diabetes patients.19)
Lisanti’s laboratory reported the caveolin-1
(CAV1)-null mice developed insulin resistance when
placed on high fat diet.20) Interestingly, insulin
signaling, as measured by IR phosphorylation and
its downstream targets, was selectively decreased in
the adipocytes of these animals while signaling in
both muscle and liver cells was normal. This signaling
defect was attributed to a 90% decrease in IR protein
content in the adipocytes, with no changes in mRNA
levels, indicating that CAV1 serves to stabilize the
IR protein.15),20) These studies clearly indicate the
AB
Fig. 2. TNF, increases the expression of GM3 and prevention of GM3 synthesis reverses TNF,-induced suppression of insulin signaling
in adipocytes. (A) 3T3-L1 adipocytes were cultured in maintenance medium without (lanes 1, 2 and 4) or with (lanes 3 and 5) 0.1nM
TNF, for 96h and in order to deplete GM3, 20µM D-PDMP was also included (lanes 4 and 5). Before insulin stimulation (100nM for
3min), cells were starved in serum-free media containing 0.5% bovine serum albumin in the absence or presence of TNF, and D-
PDMP as above for 8h. Proteins in cell lysates were immunoprecipitated with antiserum to IR and IRS-1, fractionated by SDS-
PAGE, and transferred to Immobilon-P. Western blot was then proved with anti-phosphotyrosine monoclonal antibody, stripped and
reproved with antiserum to IR and IRS-1 (B) 3T3-L1 adipocytes were incubated in the absence or presence of TNF, and D-PDMP as
in (A) and the ganglioside fraction was visualized by resorcinol staining on HPTLC.
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eolin and IR in executing successful insulin signaling
in adipocytes. Although the direct interaction be-
tween CAV1 and IR has been shown as described
above, studies of the presence of IRs in DRM
(detergent resistant membranes) have provided
conﬂicting data.21)–25) Saltiel and colleagues found
that insulin stimulation of 3T3-L1 adipocytes was
associated with tyrosine phosphorylation of CAV1.26)
However, since only trace levels of IR were recovered
in the DRM in assays with a buﬀer of 1% Triton X-
100, they speculated on the presence of intermediate
molecule(s) bridging IR and caveolin.24) Gustavsson
et al. also observed the dissociation of IRs from
caveolin-containing DRM after treatments of 0.3%
and 0.1% Triton X-100.21) It has been reported that
a comparison of protein and lipid contents of DRM
prepared with a variety of detergents indicated
considerable diﬀerences in their ability to selectively
solubilize membrane proteins and to enrich sphingo-
lipids and cholesterol over glycerophospholipids and
that Triton X-100 was the most reliable detergent.27)
Therefore, we performed a ﬂotation assay with a wide
range of Triton X-100 concentrations to identify the
protein of interest which might weakly associate with
DRM. In an assay system containing less than 0.08%
Triton X-100, we were able to show that in normal
adipocytes IRs can localize to ﬁrst time, the presence
of IR in DRM.28) The accumulation of GM3 and
cholesterol and of raft proteins (caveolin, ﬂotillin
and fyn) was conﬁrmed the DRM obtained with
0.08% Triton X-100. These results suggest the
existence of distinct and variety of rafts consisted of
functional proteins having diﬀerent binding aﬃnity
and speciﬁcity to molecules constitutively associated
with DRM.
As summarized in Table 1, there are many lines
of evidence demonstrating that the localization of IRs
GM3
SAT-I mRNA
28S rRNA
18S rRNA
ob/- ob/ob lean fatty
ob/- ob/ob lean fatty
Fig. 3. Increased GM3 synthase mRNA in adipose tissue of typical rodent models of insulin resistance. Northern blot analysis of GM3
synthase mRNA was performed using total mRNA from adipose tissues of ob/ob mice and Zucker fa/fa rats, and their lean
counterparts.
Table 1. Localization of insulin recptor (IR) in caveolae microdomains is essential for the metabolic signaling of insulin
Function Evidence Reference
Direct binding of IR and caveolin-1
IR has caveolin binding domain 17
Coimmunoprecipitation of IR and caveolin 18
Colocalization of IR and caveolin-1
IR and caveolin in light-density fractions by sucrose density ﬂoatation assay 28
Fluorescence microscope 21
Electron microscope 45, 46
Signaling
Stimulation of caveolin-1 tyrosine phosphorylation by insulin 23, 26
Caveolin deﬁcient mice show insulin resistance due to accelerated degradation
of IR in adipose tissue
20
Cholesterol depletion disrupts caveolae and metabolic signaling of insulin 12
Increased GM3 eliminates IR from DRM and inhibits IR-IRS-1 signaling 28, 29
J. INOKUCHI [Vol. 87, 182in caveolae microdomains is essential for successful
metabolic signaling of insulin.
1-3. Insulin resistance as a membrane micro-
domain disorder. In a state of insulin resistance
induced in adipocytes by TNF, we presented
evidence that the transformation to a resistant state
may depend on increased ganglioside GM3 biosyn-
thesis following upregulated GM3 synthase gene
expression. Additionally, GM3 may function as an
inhibitor of insulin signaling during chronic exposure
to TNF,.7) Since GSL, including GM3, are impor-
tant components of DRM, we have pursued the
possibility that increased GM3 levels in DRM confer
insulin resistance upon TNF-treated adipocytes. We
examined the eﬀect of TNF, on the composition and
function of DRM in adipocytes and demonstrated
that increased GM3 levels result in the elimination of
IRs from the DRM while raft marker proteins such as
caveolin and ﬂotillin remain in the DRM.28) Although
the localization of IRs to DRM may be maintained
by the association with CAV1 as mentioned above,
the excess accumulation of GM3 in the DRM may
weaken IR–caveolin interaction. Therefore, to exam-
ine interactions among IR, CAV1, and GM3 in 3T3-
L1 adipocytes, we initially performed coimmunopre-
cipitation assays. CAV1 has a scaﬀolding domain
to which IR and other functional transmembrane
proteins bind through a caveolin binding domain
in their cytoplasmic region.17),18) As expected from
another study,18) IR was co-precipitated with CAV1
(Fig. 4A). GM3 was coprecipitated with IR but not
with CAV1 (Fig. 4A, upper panel). In addition, IR
HO
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O
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O
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Photo-reactive 3 3H-labeled GM3 AB
Fig. 4. The insulin receptor forms distinct complexes with caveolin-1 (CAV1) and GM3 in adipocytes. (A) Co-immunoprecipitation
assay of Cav1 and IR. Post nuclear supernatants (PNS) of whole precipitates were subjected to SDS-PAGE followed by
immunoblotting with an anti-IRO antibody. GM3 associates with IR but not with Cav1. Upper panel: PNS were immunoprecipitated
with an anti-Cav1 antibody, an anti-IRO antibody, or an anti-mouse or anti-rat IgG. The precipitates were subjected to TLC followed
by immunostaining with the anti-GM3 antibody M2590. Lower panel: Immunoprecipitation was performed with the anti-
GM3 antibody DH2, in the presence or absence of 50µg GM3, or with anti-mouse IgG. The precipitates were then subjected to
SDS-PAGE followed by immunoblotting with an anti-IRO or anti-Cav1 antibody. (B) Cross-linking assay of GM3 and IR. Adipocytes
were treated with photoactivatable 3H-labeled GM3, washed, and then irradiated. Cells were then lysed and subjected to
immunoprecipitation with an anti-IRO antibody. PNS, anti-IRO immunoprecipitates (IP), and the supernatant from the
immunoprecipitation (Sup) were subjected to SDS-PAGE, followed by immunoblotting with an anti-IRO antibody and
autoradiography.29)
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GM3 and CAV1, suggesting that IR can form
distinct complexes with each. Alternatively, the
amount of IRs coprecipitated with GM3 was greatly
diminished by the presence of GM3, conﬁrming the
speciﬁc binding ability of the anti-GM3 antibody to
GM3 in the immunoprecipitation medium (Fig. 4A,
lower panel). We next examined GM3–protein
interactions occurring within the plasma membrane
of living cells by performing a cross-linking assay
using a photoactivatable radioactive derivative of
GM3 (Fig. 4C). Adipocytes were preincubated with
[3H]GM3(N3), then irradiated to induce cross-linking
of GM3. Target proteins were then separated by
SDS/PAGE and visualized by autoradiography. A
broad range of radioactivity reﬂecting GM3–protein
complexes could be detected from 80kDa to 200kDa,
suggesting a close association between GM3 and a
variety of cell surface proteins, including IR. More-
over, a speciﬁc radioactive band corresponding to the
90-kDa IRO-subunit was immunoprecipitated with
anti-IRO antibodies, conﬁrming the direct association
of GM3 and IR. Therefore, we found that IR form
complexes with CAV1 and GM3 independently in
3T3-L1 adipocytes.29) Lipids are asymmetrically
distributed in the outer and inner leaﬂets of plasma
membranes. In typical mammalian cells, most acidic
phospholipids are located in the inner leaﬂet, and
only acidic glycosphingolipids such as sulfatides and
gangliosides are in the outer. The binding of proteins
to lipid membranes is often mediated by electrostatic
interactions between the proteins’ basic domains and
acidic lipids. Gangliosides, which bear sialic acid
residues, exist ubiquitously in the outer leaﬂet of the
vertebrate plasma membrane. GM3 is the most
abundant ganglioside, and the primary ganglioside
found in adipocytes.30) Glycosphingolipids, including
gangliosides, is oriented at a deﬁned angle to the axis
of the ceramide.31) In addition, GM3 spontaneously
forms clusters with its own saturated fatty acyl
chains, regardless of any repulsion between the
negatively charged units in the sugar chains.32) Thus,
GM3 clusters with other cell surface gangliosides such
as GEM generate a negatively charged environment
just above the plasma membrane. Conversely, IR has
a sequence in its transmembrane domain, homo-
logous among mammals, that allows presentation
of the basic amino acid lysine (IR944) just above
transmembrane domain. Therefore, during lateral
diﬀusion an electrostatic interaction between the
lysine residue at IR944 and the GM3 cluster could
occur due to their proximity on the plasma mem-
brane (Fig. 5A). We previously developed GM3-
reconstituted cells by stably transfecting the GM3
synthase (SAT-I) gene into GM3-deﬁcient cells
(Fig. 4B, left panel).33) Using the ﬂuorescence recov-
ery after photobleaching (FRAP) technique, we
examined the mobility of IR in the plasma mem-
branes of GM3-reconstituted (GM3(D)) cells and
mock (GM3(!)) cells expressing equal levels of
CAV1 (Fig. 5B, right panel inset). The mobility of
IR-GFP expressed in the GM3(D) cells was statisti-
cally (10%) higher than that in the GM3(!) cells
(Fig. 5B, right panel), providing further evidence
that GM3 is able to enhance IR mobility by
dissociating the CAV1 and IR complex in living
cells.
The binding of between IR and CAV1 has been
studied in detail.18) To similarly understand inter-
actions between IR and GM3 have not been
analyzed. We constructed several mutants of IR in
which the lysine at IR944 was replaced with the
basic amino acid, arginine, or with the neutral amino
acid valine, serine, or glutamine. The ﬂuorescence
recovery of to those of IR(WT) and IR(K944R) in
GM3(D) cells. However, in GM3(!) cells, no such
diﬀerence in the mobility between IR(wt) and
IR(K944S) was observed (Fig. 5C). This demon-
strates that the lysine in the wild type is essential for
its binding to GM3 due to its basic charge.29)
IR may be constitutively resident in caveolae
via its binding to the scaﬀolding domain of CAV1
through the caveolin binding domain in its cytoplas-
mic region.17) In fact, there are many supporting data
showing that binding of IR and CAV1 is necessary
for successful insulin metabolic signaling (Table 1).
Iwabuchi et al. demonstrated that caveolae and GEM
could be separated by an anti-CAV1 antibody.34)
In adipocytes the localization of IR in the caveolae
is interrupted by elevated levels of the endogenous
ganglioside GM3 during a state of insulin resistance
induced by inﬂammatory response (e.g. TNF,).7)
Our latest study has proven a mechanism, at least
in part, in which the dissociation of the IR–CAV1
complex is caused by the interaction of a lysine
residue, located just above the transmembrane
domain in IRO-subunit, and the increased GM3
clustered at the cell surface by live cell studies using
FRAP techniques (Fig. 5C).29) Here, we proposed
mechanism behind the shift of IR from the caveolae
to the GEM in adipocytes during a state of insulin
resistance. Shown is a schematic representation of
raft/microdomains comprising caveolae and non-
caveolae rafts such as GEM (Fig. 6).
J. INOKUCHI [Vol. 87, 1841-4. Serum GM3 levels as a new biomarker of
metabolic syndrome. GM3 is the major ganglioside
present in serum and is known to be associated with
serum lipoproteins.35) However, there have been
no studies examining a relationship between serum
GM3 levels and adiposity indices, as well as between
serum GM3 levels and metabolic risk variables.36)
Serum GM3 levels were higher in hyperglycemic
patients (1.4-fold), hyperlipidemic patients (1.4-fold)
and hyperglycemic patients with hyperlipidemia (1.6-
fold), than in normal subjects. In addition, serum
GM3 levels were signiﬁcantly increased in type 2
diabetic patients with severe obesity (visceral fat area
>200cm2, BMI >30). The GM3 level was positively
correlated with LDL-c (0.403, P F 0.012) in type 2
diabetes mellitus, but not aﬀected by blood pressure.
In addition, the high levels of small dense LDL
(>10mg/gl) were associated with the elevation of
GM3. Serum GM3 levels were aﬀected by glucose
and lipid metabolism abnormalities and by visceral
obesity. Interestingly, small dense LDL is reportedly
associated with the development of atherosclero-
sis,37)–39) and GM3 has been detected in atheroscler-
otic lesions.40),41) Thus, our ﬁndings provide evidence
that GM3 may be a useful marker for the manage-
ment of metabolic syndrome including insulin resist-
ance, as well as for the early diagnosis of athero-
sclerosis. We are in the process to expanding the
number of patients suﬀered from various stages of
metabolic disorders to measure GM3 levels in serum
as well as in insulin responsive organs such as muscle
and adipose tissues.
1-5. A possible therapeutic intervention of
metabolic syndrome by inhibiting ganglioside
synthesis. Critical involvement of GM3 in insulin
resistance and metabolic syndrome including type 2
diabetes has now became evident based on the
following key observations; (i) TNF, increases the
expression of GM3 in adipocytes and the TNF,-
induced insulin resistance is prevented by treatment
with a glucosylceramide synthase inhibitor, D-
PDMP, and decreases GM3 contents.7) Recently, an
A
B
C
Fig. 5. The lysine residue IR944 is essential for the interaction of IR with GM3. (A) Schematic representation of the proposed interaction
of the lysine residue at IR944, which is located just above the transmembrane domain, and GM3 at the cell surface. (B) Enhanced
mobility of IR in GM3-enriched membrane. Left panel: Glycosphingolipid (GSL) analysis of GM3-reconstituted cells (GM3(D)) and
mock cells (GM3(!)). GSLs extracted from these cells, corresponding to 1mg of cellular protein, were separated on HPTLC plates
and stained with resorcinol-HCl reagent, to visualize gangliosides, or with cupric acetate-phosphoric acid reagent and GM3(D) cells
expressing equal levels of caveolin-1 (Cav1) (inset). (C) Speciﬁcity of the interaction between lysine at IR944 and GM3 by FRAP
analyses. Upper panel: Schematic structure of IR-GFP mutants in which the lysine at IR944 is replaced with basic and neutral amino
acids. Lower panel: Fluorescence recovery of IR-GFP mutants in GM3(D) and GM3(!) cells.
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glucosylceramide synthase inhibitor,44) were proven
to have therapeutic value by oral administration
in diabetic rodent models. These glucosylceramide
synthase inhibitors were able to improve insulin
sensitivity and glucose homeostasis in rodent models
of obesity;42)–44) (ii) GM3 contents increase in the
adipose tissue of Zucker fa/fa rats and ob/ob mice,
which are typical rodent models of obesity7) and diet
induced obesity. Indeed, when we fed high fat diet for
10 weeks to wild type mice and SAT-I deﬁcient mice,
both mice became obese similarly. Nevertheless, in
the obese SAT-I deﬁcient mice, the expression levels
of TNF, in mesenteric adipose tissues was signiﬁ-
cantly lower than those in the obese B6 mice,
providing the evidence that the enhancement of
GM3 levels in adipose tissue under obese conditions
is upstream and causal event in the progression of
metabolic syndrome (unpublished observation); (iii)
insulin sensitivity is enhanced in SAT-I deﬁcient
mice;9) (iv) the accumulation of GM3 in insulin
resistance results in dissociation of the insulin
receptor from caveolae;28) (v) dissociation of the
insulin receptor from caveolae is caused by electro-
static interaction between GM3 and the lysine
residue (Lys-944) located just above the transmem-
brane of the insulin receptor.29) Thus these data
substantiate a rationale for designing novel therapies
against type 2 diabetes and related diseases based
on inhibition of ganglioside biosynthesis.29) Here I
have summarized the distinct pathway of metabolic
disorder including the aberrant expression of GM3
(Fig. 7).
2. Gangliosides in auditory system
and hearing loss
Sounds from the outside world propagate
through the external and middle ears then stimulate
the inner ear. The mammalian inner ear contains the
sensory organ known as the “cochlea” (Fig. 8). The
organ of Corti sits in the scala media, which houses
hair cells arrayed on the basilar membrane along the
Fig. 6. Proposed mechanism behind the shift of insulin receptors from the caveolae to the glycosphingolipid-enriched microdomains
(GEM) in adipocytes during a state of insulin resistance. A schematic representation of raft/microdomains comprising caveolae and
non-caveolae rafts such as GEM. Caveolae and GEM reportedly can be separated by an anti-CAV1 antibody. IR may be
constitutively resident in caveolae via its binding to the scaﬀolding domain of CAV1 through the caveolin-binding domain in its
cytoplasmic region. Binding of IR and CAV1 is necessary for successful insulin metabolic signaling (Table 1). In adipocytes the
localization of IR in the caveolae is interrupted by elevated levels of the endogenous ganglioside GM3 during a state of insulin
resistance induced by TNF,.29) The present study has proven a mechanism, at least in part, in which the dissociation of the IR/CAV1
complex is caused by the interaction of a lysine residue at IR944, located just above the transmembrane domain, and the increased
GM3 clustered at the cell surface.
J. INOKUCHI [Vol. 87, 186length of cochlea duct. The cochlea harbors about
15,000 sensory hair cells, which are the mechano-
receptors of hearing. These cells are responsible for
translating auditory stimuli into electrical energy
that can be perceived by the nervous system (Fig. 8).
Hair cells are sensitive to mechanical and chemical
insults, so they can be easily acoustical overstimula-
tion, and by the eﬀects of aging. The impairment and
loss of hair cells in the cochlea are responsible for a
signiﬁcant proportion of sensorineural hearing im-
pairment. While cells in many organs (such as the
skin and gut epithelium) are constantly replenished
throughout life, other organs such as the liver are
even capable of regeneration following injury, no hair
cell replacement or cell proliferation occurs in the
mammalian cochlea. This inability is the major
reason for the diﬃculties faced in the fundamental
treatment of hearing loss.47)
Many deafness-related genes have been reported,
and it is estimated that more than 100 are expressed
in the inner ear. These facts suggest that the
regulation of the function and maintenance of the
inner ear is precise and complex. Identifying the
mechanisms active in hearing loss caused by these
deafness-related proteins and their encoded proteins,
and understanding their interrelationships at the
molecular level will could provide a basis for the
design of novel practical therapies for sensorineural
hearing loss.
Cell-surface glycoconjugates including proteo-
glycans, glycoproteins, and glycosphingolipids have
been suggested to serve important functions in
hearing because of their variety and speciﬁc expres-
sion patterns during the development and matura-
tion of cochlea. However, there has been no deﬁnitive
proof regarding their involvement in auditory func-
tions. In this review, we provide an overview of
the expression of glycoconjugates in tissues of the
auditory system, and of their possible involvement in
hearing function including our recent ﬁndings regard-
ing deafness in SAT-I knockout mice.
2-1. Expression of glycans in the cochlea.
The abundance of glycans in the cochlea was ﬁrst
suggested in the 1980’s in tissue studies using Alcian
blue metachromasia, periodate-Schiﬀ staining and
ruthenium red staining. Subsequently, the variety
and speciﬁc expression patterns of some glycoconju-
gates were demonstrated by newly developed tools
such as lectin and antibody detection of speciﬁc
carbohydrate structures (Table 2). It was reported
Fig. 7. Insulin resistance through increased GM3 levels in metabolic syndrome. MCP-1: monocyte chemotactic protein-1; MH:
macrophage.
Hematoside and GM3 No. 4] 187that the expression levels and distribution of some
carbohydrate structures within the cochlea changed
signiﬁcantly during development and maturation.
For example in mice at gestation day 19, glycoconju-
gates strongly positive for staining with wheat germ
agglutinin (WGA), which reacts with N-acetylglucos-
amine and/or sialic acid in glycans, were detected in
the apical surface of the outer hair cells (OHC) and
the inner hair cells (IHC), but not in the basolateral
region. On the day of birth, the strong WGA-positive
signal was detected in the intracellular region of the
apical side of the epithelial cells, including the hair
cells. Furthermore, an intracellular reaction to WGA
was also detected in the area of the supporting cells.
From postnatal day 10 onward, the intracellular
WGA reaction decreased. In another example using
Concanavalin A, a lectin that reacts with high
mannose-type glycans of glycoproteins, intense
staining of the supporting cells and the tectorial
membranes (TM) was observed.48) Immunohistology
of guinea pig cochlea tissue using a panel of 25
monoclonal antibodies directed to various carbohy-
drate epitopes identiﬁed lacto-series structures local-
ized at speciﬁc sites of the TM and the organ of
Corti.49)
These distinct and spatiotemporal expression
proﬁles of speciﬁc glycoconjugate species in inner ear
during development and maturation suggest their
critical roles in the auditory system. Details of the
molecular functions of each glycoconjugate in hearing
are largely unknown. However, as described below,
hearing loss has been reported in certain human
diseases caused by the mutation of genes involved in
glycoconjugate metabolism, and in transgenic mice
carrying mutations related to glycoconjugate metab-
olism.
2-2. Hearing loss in human diseases related
to glycoconjugate metabolism. Hearing loss has
been reported in some lysosomal storage diseases
(LSDs) resulting from the mutation of enzymes
related to intralysosomal hydrolysis of glycoconju-
gates; such diseases include sialidosis, mucopolysac-
Stria vascularis
Organ of Corti
Basilar membrane
Scala vestibuli
Scala tympani
Scala media
ion
Ion channel
Actin filament
Acoustic
stimuli
A
B
Spiral Ganglion
Inner hair cell
Outer hair cell
Tectrial membrane
Cochlea
Reissners membrane
Tip link
Fig. 8. Structure of the cochlea and organ of Corti (A) and Sensing and transduction of sounds in the stereocilia (B). Hair cells detect
sound through deﬂection of mechanosensory “stereocilia”, actin-based microvilli-like projections on their apical surface. Each
stereocilium is supported by a paracrystalline array of parallel actin ﬁlaments. The sound-induced deﬂections impel tension in the tip
links between the stereocilia and stimulate cation-selective mechanotransduction channels present on the stereocilia. This process
permits endolymphatic KD to enter the hair cells, resulting in their electrical excitation.
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gangliosidosis (Sandhoﬀ’s disease), and ,-a n dO-
mannosidosis.50)–53) Sensorineural defects in the inner
ear have been reported in LSD patients, as have
conductive abnormalities in the middle and external
ears. Hearing loss has also been reported in the
hereditary multisystemic disorders termed congenital
disorders of glycosylation (CDG) type I, which are
caused by a disruption in the production of lipid-
linked oligosaccharides necessary for generation of
nascent glycoproteins in the endoplasmic reticulum.
CDG type Ig (CDG-Ig) is caused by a deﬁciency
of the ,-mannosyltransferase. dolichyl-P-mannose:
Man-7-GlcNAc-2-PP-dolichyl-,-6-mannosyltransfer-
ase, which is encoded by the gene ALG12. In CDG
Ig patients, Man-7-GlcNAc-2-PP-dolichol is poorly
transferred to protein and so is accumulated. Certain
patients with CDG-Ig share many common clinical
features, including sensorineural hearing loss, as well
as male genital hypoplasia, IgG deﬁciency, psycho-
motor retardation, and blindness.54) Although the
molecular mechanisms of the sensorineural hearing
Table 2. Expression of glycoconjugates in cochlea
Expression region Glycan structure & reactive lectins Animals Reference
Organ of Corti
B-, H-blood group antigen Rat 64
keratan sulfate Guinea pig 65
chondroitin 4-sulfate 66
GT1b, GM3 Mouse 60
poly-sialic acid Rat 67
Mouse 68
WGA, ConA, SBA, PSA, RCA-II, PHA-E Mouse 48
Tectrial membrane
Lex,L e y, sLex, sialyl-unbranched type2 chain Guinea pig 49
chondroitin 4-, or 6-sulfate, keratan sulfate Gerbil 69
keratan sulfate Chinchilla 70
LFA, GSA II, DBA, SJA, VVA, SBA, APA, Gerbil 71
UAE-I, LTA, ConA, LCA, PSA, RCA-I, MPA Guinea pig 71
WGA, DSA, PWM, E-PHA, L-PHA Rat 71
Mouse 71
WGA, APA, UAE-I, RCA120, HPA, ConA Human 72
Stria vascularis
sLex, sialyl-unbranched type2 chain, Guinea pig 49
GM3, 9-O-Ac GD3, GD2/GD3
heparan sulfate Chinchilla 73
Rat 74
keratan sulfate Chinchilla 70
GM3 Mouse 60
WGA, APA, RCA120, HPA Human 72
WGA, ConA, DBA, PNA, RCA-I, SBA Rat 75
Spiral ganglion
heparan sulfate Chinchilla 73
poly-sialic acid Rat 67
Mouse 68
GM3, GD2/GD3 Guinea pig 49
GM3 Mouse 60
Reissners membrane
heparan sulfate Mouse 76
Rat 74
WGA, APA, RCA120, HPA, ConA Human 72
Unknown (TLC analysis)
GM3, GM1, GT1b, GQ1b Chinchilla 77
GM3, GM1, GM2, GD3, GD1a,b, GT1b, GalCer, SM4 Rat 78
GM3, GM1, GD3, GD1a,b, GT1b, LacCer, GlcCer, SM4, SM3 Mouse 60
Hematoside and GM3 No. 4] 189defects present in LSD and CDG Ig patients are
generally unclear, these facts nevertheless indicate
that proper metabolism of glycoconjugates is indis-
pensable for the maintenance of hearing ability.
Another example which would seem to support
the importance of glycosylation in normal hearing
involves the protein clarin-1. Clarin-1 belongs to
a superfamily of four-transmembrane proteins that
includes the tetraspanin and claudin families. The
gene encoding clarin-1 is mutated in some types of
Usher syndrome, a human inherited disorder causing
deafness and blindness. When expressed in HEK293
cells, clarin-1 localizes to the plasma membrane and
becomes concentrated in low density compartments,
possibly in some type of microdomains. In addition,
clarin-1 reorganizes actin ﬁlament structures and
induces lamellipodia. In North America, the most
prevalent mutation in Usher syndrome III is the
clarin-1 N48K mutation, which causes a defect in
N-linked glycosylation. N48K mutant proteins are
quickly degraded by the proteasomal pathway,
resulting in a loss in actin-reorganizing function.
Consistent with this phenomenon, in hair cells from
mice deﬁcient in clarin-1, F-actin-enriched stereocilia
exhibit structural disorganization.55) These observa-
tions suggest a possible role for clarin-1 and its
glycosylation in the regulation and homeostasis of
stereocilia.
2-3. Mice lacking ganglioside GM3 synthase
(SAT-I) exhibit complete hearing loss due to
selective degeneration of the organ of Corti. We
generated SAT-I-deﬁcient mice and examined their
general physiological characteristics. In most tissues
of the SAT-I-deﬁcient mice, all of the a-, b- and c-
series gangliosides are converted to o-series ganglio-
sides, including GM1b and GD1,, which are
produced by bypassing GM3 synthesis (Fig. 1).
During observations of their general behavior, we
found that SAT-I!/! mice exhibited no acoustic
reﬂex, indicating a loss of hearing. Three-month-old
SAT-ID/D mice exhibited acoustic startle responses
to stimuli 85dB and higher, however the littermate
SAT-I!/! mice exhibited no startle reﬂex in response
to any acoustic stimulation (Fig. 9A, left panel). In
contrast, all littermate mice demonstrated normal
startle responses to air puﬀs administered to their
backs (Fig. 9A, right panel), suggesting an impair-
ment in the hearing ability of mice deﬁcient in SAT-I.
The auditory brain-stem response (ABR) repre-
sents the average surface ﬁeld potential recorded
activity of the auditory neural generators of the lower
auditory pathway.56) We performed an ABR study as
an objective hearing test on 8-week-old mice using a
click sound stimulus of up to 85dBSPL. Although
SAT-ID/D mice exhibited normal and reproducible
ABR peaks, in SAT-I!/! mice all ABR peaks were
missing, suggesting that the impaired hearing was
due to abnormalities in the cochlear nerve and/or
inner ear function (Fig. 9B). Visual observations of 6
to 8-week-old SAT-I littermates indicated no struc-
tural diﬀerences in the middle and the external ear
between the SAT-ID/D and SAT-I!/! mice. Subse-
quently, we performed histological examinations of
cochlea (Fig. 9C). In SAT-I!/! mice, the organ of
Corti was completely missing, although the other
regions of cochlea, including the Reissner’s mem-
brane (RM), stria vascularis (SV), and the tectorial
membrane (TM), appeared to be normal (Figs. 9C
and 10B). Probably, as a consequence of the loss
of hair cells, the spiral ganglion (Fig. 9C; SG) was
scattered.57)
We considered the possibility that the degen-
eration of the organ of Corti in the SAT-I!/! mice
might be secondarily induced by changes in the
endolymph, an extracellular ﬂuid produced and
maintained by the SV that is critical to mechano-
electron transduction.58) To address this question,
we next measured the endocochlear potential (EP)
and KD concentrations in the emdolymph. There
were no signiﬁcant diﬀerences in EPs and the KD
concentrations between SAT-ID/D and SAT-I!/!
(Fig. 10A), proving that the profound hearing loss
in the SAT-I null mice at 8-week-old resulted from
the loss of mechano-electro transduction was induced
by the primary loss of the organ of Corti, not by the
secondary consequence from metabolic changes in the
endolymph. In addition, histological studies of the
vestibule in the SAT-I!/! mice revealed no abnor-
mality (Fig. 10C), consistent with the normal bal-
ance and motor function of the mice when tested on a
rota-rod (Fig. 10D).
As summarized the phenotypes of SAT-I-deﬁ-
cient mice in Fig. 11A, their hearing ability measured
by ABR is seriously impaired at the day of hearing
onset, around postnatal day 14, and is completely
lost after a few days.59) In the cochlea of these mice,
degeneration of the stereocilia of hair cells in the
organ of Corti is apparent during the postnatal
period of cochlea maturation (Fig. 11B). Normally,
various ganglioside species (GM3, GM1, GD1a,
GD1b, and GT1b) are expressed in the mouse
cochlea. In the inner ear of SAT-I!/! mice, however,
only GM1b and GD1, are expressed (Fig. 12A).
Interestingly, spatiotemporal changes in localization
J. INOKUCHI [Vol. 87, 190of individual gangliosides including GM3 and GT1b
were observed during the postnatal development and
maturation of the normal inner ear. GM3 expressed
in almost all regions of cochlea at P3 but on the onset
of hearing distinctly localized in stria vascularis,
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Fig. 10. Function and histology of Stria vascularis and vestibule
in adult SAT-I!/! mice. (A) Endocochlear potential (EP) and
potassium ion (KD) concentrations in the endolymph of 6- to
8-week-old SAT-ID/D (open bar) and SAT-I!/! (closed bar) mice
are illustrated. The vertical axis displays mV for EP and mM
for KD concentration. Each bar represents the mean ’ S.E.
There were no signiﬁcant diﬀerences in the EP or the KD
concentrations between the SAT-ID/D and SAT-I!/! mice.
(B) Microscopic examination of the stria vascularis, stained
with hematoxylin and eosin, of 8-week-old SAT-ID/D (left) and
SAT-I!/! (right) mice. No gross diﬀerence was detected. Scale
bar: 50µm. (C) Histological examination of the vestibule from
an 8-week-old SAT-I!/! mouse. Despite the disappearance of the
organ of Corti (arrow head), the layer of hair cells at the sacculus
(arrow) and macula statica (the structure faintly stained with
eosin above the layer of hair cells) is apparent, and appears to be
normal when compared with the control sections of SAT-ID/D
mice (not shown). The inset shows a magniﬁed view of the hair
cell layer indicated by the arrow, and demonstrates stereocilia
harbored at the apical side of the hair cells. Scale bar: 100µm.
(D) Motor coordination of SAT-I littermates. SAT-ID/D (n F 10)
and SAT-I!/! (n F 11) mice were tested on a rota-rod. The
latency to fall was measured at 10 and 15rpm. Values are
expressed as means ’ S.E.
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Fig. 9. Lack of auditory brain stem response due to the selective
degeneration of the organ of Corti. (A) Startle response in 12-
week-old SAT-ID/D (n F 10) and SAT-I!/! (n F 9) mice following
acoustic stimuli (70, 75, 80, 85, 90, 100, 110 and 120dBSPL) or air
puﬀ. Data represent the means ’ S.E. *P < 0.001; signiﬁcantly
diﬀerent from the corresponding vehicle-treated group by
Student’s t test or the Aspin–Welch test. (B) Auditory brain
stem responses (ABR) were obtained from 8-week-old mice (SAT-
ID/D and SAT-I!/! littermates) responding to click stimuli up to
85dBSPL. Patterns from SAT-ID/D mice indicate normal ABR;
the pattern from a SAT-I!/! mouse reveals no ABR. Representa-
tive data for each littermate group (n F 6) are presented. (C)
Histology of cochlea. Tissue sections of cochlea in 8-week-old
SAT-ID/D and SAT-I!/! mice were prepared and stained with
hematoxylin and eosin. The organ of Corti with outer hair cells
(OHC) and inner hair cells (IHC), Reissner’s membrane (RM),
tectorial membrane (TM) and stria vascularis (SV) appear to be
normal in SAT-ID/D spiral ganglion (SG) mice. In contrast, the
organ of Corti (OC) is completely missing in the cochlea of SAT-
I!/! mice.Allscalebarsrepresent100µm. Representativedatafor
each littermate group (n F 6) are presented.
Hematoside and GM3 No. 4] 191spiral ganglion, and the organ of Corti (Fig. 12B).
These observations suggest that the expression of
proper gangliosides during the early period of the
functional maturation of the cochlea is essential for
the acquisition and maintenance of hearing ability.
2-4. Role for microdomains in auditory
systems. It has been reported that double knockout
mice targeted to both GM2/GD2 and GD3 syn-
thases, expressing only GM3, responded to acoustic
stimulations.60) Therefore, it is considered that the
lack of GM3 may cause the degeneration of the organ
of Corti. During the course of studies mentioned in
the previous section 2-3, we also found that GM3
may have speciﬁc functions in the stereocilia of hair
cells. As shown in Fig. 13A, stereocilia of inner hair
cells was distinctly stained by anti-GM3 antibody,
where the ﬁrst lesion was occurred in SAT-I!/! mice
at P8.59)
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cells that carry out auditory and vestibular trans-
duction. Stereocilia are microvillus- or ﬁlopodium-
like cellular processes on the apical surface of hair
cells. Each stereocilium is ﬁlled with hundreds of
crosslinked actin ﬁlaments, and certain proteins are
speciﬁcally expressed in these stereocilia, such as
unconventional myosins, Usher proteins, and some
deafness-related gene products. These molecules are
localized in distinct regions and interact with other
speciﬁc proteins within the stereocilia to maintain
the cells’ mechanoelectro-transduction (Fig. 13B).61)
Auditory hair cells must have a system for trans-
porting speciﬁc proteins to stereocilia, although none
have been identiﬁed. One may speculate that some
type of functional microdomain like rafts must
also exist in apical surface stereocilia, and available
data actually support this hypothesis. Several deaf-
ness-related gene products, including prestin and
clarin-1,62),55) can be biochemically isolated in deter-
gent-resistant membrane microdomains (DRMs/lipid
rafts) when over-expressed in conventional cell lines
(i.e., HEK293 cells). In addition, some deafness-
related gene products are localized in spatially
restricted regions of the stereocilia, for example the
membrane glycoproteins, PTPRQ, cadherin23, pro-
tocadherin15, Usherin, VLGR1. submembrane region
of stereocilia. These proteins form a network via
speciﬁc interactions to form distinct functional
regions in stereocilia.
The molecular mechanisms of hearing loss in
SAT-I!/! mice remain to be determined. Never-
theless, these ﬁndings demonstrate a direct link
between gangliosides and hearing functions. We are
underway to elucidate functional molecule(s) selec-
tively expressing in the stereocilia interacting with
GM3 to maintain its function and integrity using hair
cell-like cells derived from embryonic and induced
pluripotent stem cells.63)
3. Perspective
The functional roles of GM3 had been examined
indirectly by the addition of exogenous GM3 to
culture medium or by the depletion of precursor
glycosphingolipids using inhibitors of glucosylcera-
mide synthase (reviewed in ref. 79). These results
suggest that GM3 may be involved in the trans-
membrane signaling by regulating growth factor
receptor activities and in cell adhesion and motility
by interacting with integrins and/or integrin-related
molecule(s). However, it has not been conclusively
demonstrated that the eﬀect of exogenously added
gangliosides or pharmacologically depleted ganglio-
sides reﬂects the biological function of endogenous
GM3.
As described in this review, our research employ-
ing GM3 synthase gene and its knockout mice has
proved the critical involvement of GM3 in diabetes
A
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Fig. 12. Analysis of gangliosides in mouse inner ear. (A) Thin
layer chromatograms of acidic (right panel) and neutral (left
panel) glycolipids from the inner ear of 6- to 8-week-old SAT-
ID/D, SAT-ID/!, and SAT-I!/! mice. In SAT-ID/D and SAT-ID/!
mice, GM3, GM1, GD1a, GD1b and GT1b are expressed in the
inner ear, but these gangliosides are absent in the SAT-I!/!
mouse, and the o-series, GM1b and GD1, are compensatorily
expressed due to blockage of GM3 synthesis (Fig. 1). (B)
Localization of GM3 and GT1b in the cochlea of SAT-ID/D mice
at P3 and P14. At P3, GM3 and GT1b are expressed in almost all
regions of the cochlea. At P14, both are expressed in the organ of
Corti (OC), however, GM3 is expressed in the SV and SG, but in
contrast,GT1b isexpressedin regions distinctfromGM3, such as
the spiral ligament, spirallimbus. All scale bars represent200µm.
Hematoside and GM3 No. 4] 193and hearing function during the past decade. In
addition, on going study we are elucidating the
indispensable role of GM3 in helper T cell function,
because GM3 synthase-deﬁcient mice did not develop
asthma (ovoalbumin-induced airway hypersensitiv-
ity) (data not shown). Thus, our data substantiate
a rationale for designing novel therapies against the
metabolic syndrome including type 2 diabetes and
immunological disorders such as allergy based on
inhibition of GM3 biosynthesis. The extensive
reduction of all gangliosides by inhibiting GM3
biosynthesis would carry to important physical and
chemical modiﬁcations of the all cellular plasma
membrane and in particular of lipid microdomains.
However, we expect that such extensive depletion of
gangliosides will not be necessarily for the treatment
of metabolic disorders. When we demonstrated the
eﬀectiveness of D-PDMP on the impaired insulin
signaling in TNF,-treated 3T3-L1 adipocytes, the
normalization of elevated levels of GM3 was enough
to ameliorate the state of insulin resistance.7)
Gangliosides expressing cell-type speciﬁc man-
ner are expected to interact with various functional
molecules on plasma membranes based on diﬀerent
potential of non-covalent bonding such as electro-
static and hydrophobic interactions and thereby
ganglioside family could participate various aspects
of cellular activities by forming dynamic supra-
biomolecular complexes in living cell membranes.
Namely, the presence of membrane microdomains
(rafts) reﬂecting characteristics of individual cells.
Gangliosides accumulate in microdomains because
Myo XV
Myo IIIa
Myo Ic, VIIa
Myo VI
specific proteins
interact with each Myo
Actin filament
Tip link
(Cdh23, Pcdh15
Ion channels)
Myo Ic and/or VIIa
region
Myo VI
region
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Myo IIIa region
Ankle link
(VLGR1, Usherin)
Shaft connector
(PTPRQ)
A
B
Fig. 13. GM3 expresses the stereocilia of hair cells. (A) Whole mount staining of stereocilia of inner hair cells by anti-GM3 antibody and
phalloidin. Scale bar represents 5µm. (B) Diagram of two neighboring stereocilia. Myosins XVa and IIIa are both localized at the tip
of each stereocilium, but while myosin XVa localizes to the extreme tip region, myosin IIIa extends further down the stereocilium
shaft. Myosin VI localizes at the stereocilium base, and Myosins VIIa and Ic along the shaft. Each myosin interacts and co-localizes
with other speciﬁc proteins in the stereocilium for the formation of functional networks which links the inside and outside of the
plasma membrane. And some membrane glycoprotein are also localized in speciﬁc functional region, such as ‘tip link’ (cdh23, Pcdh15,
ion channels), shaft connector (PTPRQ) and Ankle links (Usherin, VLGR1).
J. INOKUCHI [Vol. 87, 194hydrogen donor and acceptor, and saturated and
relatively long acyl chains compared to those of
phospholipids should be exist in their ceramide
backbone to accelerate their self aggregation. More-
over, since gangliosides expose sialic acid residue
to outside of outer leaﬂet membranes, it is very
interesting to know their true physiological counter-
parts for electrostatic interactions in microdomains.
Comprehensive study to elucidate the functional
supra-biomolecular complex consisting of ganglio-
sides and functional proteins in microdomains should
generate a novel concept and strategy “membrane
microdomains ortho-signaling therapy”.
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